Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details)

v3.20.2
Stock Based Compensation (Details)
6 Months Ended
Jun. 30, 2020
USD ($)
$ / shares
shares
Number of shares  
Number of shares, Beginning balance | shares 12,553,326
Number of shares, Grants | shares 250,000
Number of shares, Expiration | shares (356,000)
Options exercisable, Ending balance | shares 12,322,326
Weighted Average Exercise Price  
Weighted Average Exercise Price, Beginning balance | $ / shares $ 0.55
Weighted Average Exercise Price, Grants | $ / shares 0.19
Weighted Average Exercise Price, Expiration | $ / shares 0.59
Options exercisable, Ending balance | $ / shares $ 0.54
Weighted Average Remaining Contractual Life (years)  
Weighted Average Remaining Contractual Life (years), Beginning balance 4 years 7 days
Weighted Average Remaining Contractual Life (years), Grants 5 years
Weighted Average Remaining Contractual Life (years), Expiration
Weighted Average Remaining Contractual Life (years), Ending balance 3 years 7 months 6 days
Options exercisable, Ending balance 3 years 7 months 2 days
Aggregate Intrinsic Value  
Aggregate Intrinsic Value, Beginning balance | $ $ 927
Options exercisable, Ending balance, Intrinsic value | $ $ 1,734